| Lori M Kagy, MD | |
|
5 Executive Center Ct, Little Rock, AR 72211-4375 | |
| (501) 227-5210 | |
| (855) 656-7325 |
| Full Name | Lori M Kagy |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 25 Years |
| Location | 5 Executive Center Ct, Little Rock, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598744625 | NPI | - | NPPES |
| 136718001 | Medicaid | AR | |
| A009 | Other | AR | CHAMPUS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | E-2107 (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Psf Pllc | 1557265543 | 98 |
News Archive
ValGenesis, Inc., a world-class provider of Validation Lifecycle Management Systems (VLMS), announced today that its innovative ValGenesis Suite 2.5 has achieved SAP certification as powered by the SAP NetWeaver technology platform. Attaining this certified integration status deepens ValGenesis' active and on-going commitment to SAP® solutions.
For the first six months, IT and medical technology company Sectra reported a 15.8% increase in net sales to SEK 453.6 million (391.7). Operating profit totaled SEK 7.6 million (16.5), corresponding to an operating margin of 1.7% (4.2). Profit after net financial items was SEK 2.4 million (4.4).
Scientists at Emory University School of Medicine have identified a new type of anti-inflammatory compound that may be useful in treating a wide range of conditions, including neurodegenerative and autoimmune diseases. These compounds inhibit the enzyme Nox2, part of a family of enzymes responsible for producing reactive oxygen species (ROS).
Valsartan, an angiotensin II receptor blocker drug, delayed disease progression and improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to results from a recent clinical trial published in Nature Medicine.
Researchers affiliated with the Kawasaki INnovation Gateway at SKYFRONT, have successfully developed a humanized mouse model showing that so-called NK cells that directly attacking tumors, can survive and maintain function in vivo.
› Verified 2 days ago
| Entity Name | Psf Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881785947 PECOS PAC ID: 1557265543 Enrollment ID: O20200625000505 |
News Archive
ValGenesis, Inc., a world-class provider of Validation Lifecycle Management Systems (VLMS), announced today that its innovative ValGenesis Suite 2.5 has achieved SAP certification as powered by the SAP NetWeaver technology platform. Attaining this certified integration status deepens ValGenesis' active and on-going commitment to SAP® solutions.
For the first six months, IT and medical technology company Sectra reported a 15.8% increase in net sales to SEK 453.6 million (391.7). Operating profit totaled SEK 7.6 million (16.5), corresponding to an operating margin of 1.7% (4.2). Profit after net financial items was SEK 2.4 million (4.4).
Scientists at Emory University School of Medicine have identified a new type of anti-inflammatory compound that may be useful in treating a wide range of conditions, including neurodegenerative and autoimmune diseases. These compounds inhibit the enzyme Nox2, part of a family of enzymes responsible for producing reactive oxygen species (ROS).
Valsartan, an angiotensin II receptor blocker drug, delayed disease progression and improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to results from a recent clinical trial published in Nature Medicine.
Researchers affiliated with the Kawasaki INnovation Gateway at SKYFRONT, have successfully developed a humanized mouse model showing that so-called NK cells that directly attacking tumors, can survive and maintain function in vivo.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lori M Kagy, MD 9800 Shelbyville Rd, Ste 220, Louisville, KY 40223-2992 Ph: (502) 429-8585 | Lori M Kagy, MD 5 Executive Center Ct, Little Rock, AR 72211-4375 Ph: (501) 227-5210 |
News Archive
ValGenesis, Inc., a world-class provider of Validation Lifecycle Management Systems (VLMS), announced today that its innovative ValGenesis Suite 2.5 has achieved SAP certification as powered by the SAP NetWeaver technology platform. Attaining this certified integration status deepens ValGenesis' active and on-going commitment to SAP® solutions.
For the first six months, IT and medical technology company Sectra reported a 15.8% increase in net sales to SEK 453.6 million (391.7). Operating profit totaled SEK 7.6 million (16.5), corresponding to an operating margin of 1.7% (4.2). Profit after net financial items was SEK 2.4 million (4.4).
Scientists at Emory University School of Medicine have identified a new type of anti-inflammatory compound that may be useful in treating a wide range of conditions, including neurodegenerative and autoimmune diseases. These compounds inhibit the enzyme Nox2, part of a family of enzymes responsible for producing reactive oxygen species (ROS).
Valsartan, an angiotensin II receptor blocker drug, delayed disease progression and improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to results from a recent clinical trial published in Nature Medicine.
Researchers affiliated with the Kawasaki INnovation Gateway at SKYFRONT, have successfully developed a humanized mouse model showing that so-called NK cells that directly attacking tumors, can survive and maintain function in vivo.
› Verified 2 days ago
Dr. Donna Melissa Graham, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 500 S University Ave, Suite 215, Little Rock, AR 72205 Phone: 501-420-1085 Fax: 501-420-1457 | |
Eddie W Shields, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 5 Executive Center Ct, Little Rock, AR 72211 Phone: 501-227-5210 Fax: 855-656-7325 | |
Dr. Deanna N. Ruddell, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 16101 Cantrell Rd Ste 104, Little Rock, AR 72223 Phone: 501-425-0322 | |
Lindsay M. Still, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 5 Executive Center Ct, Little Rock, AR 72211 Phone: 501-227-5210 Fax: 855-656-7325 | |
Dr. Jim Mark Ingram, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 18 Corporate Hill Dr, Suite 110, Little Rock, AR 72205 Phone: 501-224-1156 Fax: 501-801-5561 | |
Dr. Meredith Dilley, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 10201 Kanis Rd, Little Rock, AR 72205 Phone: 501-227-5050 | |
Kelly D Burks, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 5 Executive Center Ct, Little Rock, AR 72211 Phone: 501-227-5210 Fax: 855-656-7325 |